Brief: Senzime Q4 EBITDA SEK -34.655 Million
15/02/2024 06:30
Feb 15 (Reuters) - Senzime Q4 EPS SEK -0.33. * Q4 adjusted gross margin 70.8% * Q4 sales SEK 10.85 million
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona